Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EN20-01: A 24 Week Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Moderate to Severe Knee Osteoarthritis Pain.

NCT05025787 is registered in ClinicalTrials.gov with Maurizio Fava, MD as lead sponsor.

NCT NCT05025787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05025787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EN20-01: A 24 Week Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Moderate to Severe Knee Osteoarthritis Pain.
Lead sponsor
Maurizio Fava, MD
Phase
Phase 2
Overall status
Completed
Start date
October 25, 2021
Completion date
June 11, 2024
Enrollment
55 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis